Vaccine Wars | Long Shot | 3

Business Wars

It’s February 2020 and drugmaker Moderna’s sprinting ahead – its Covid vaccine is already poised to enter human trials.

But Moderna and its rivals know plenty of vaccines never make it out of trials alive. It’s also going to take a lot of manufacturing muscle to inoculate the world. All of which costs a lot of moolah.

And if the vaccine makers can’t secure a deep-pocketed partner in time, they’re going to get disqualified from the race.

Listen to new episodes 1 week early and to all episodes ad free with Wondery+. Join Wondery+ for exclusives, binges, early access, and ad free listening. Available in the Wondery App https://wondery.app.link/businesswars.


Support us by supporting our sponsors!

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

More description

It’s February 2020 and drugmaker Moderna’s sprinting ahead – its Covid vaccine is already poised to enter human trials.

But Moderna and its rivals know plenty of vaccines never make it out of trials alive. It’s also going to take a lot of manufacturing muscle to inoculate the world. All of which costs a lot of moolah.

And if the vaccine makers can’t secure a deep-pocketed partner in time, they’re going to get disqualified from the race.

Listen to new episodes 1 week early and to all episodes ad free with Wondery+. Join Wondery+ for exclusives, binges, early access, and ad free listening. Available in the Wondery App https://wondery.app.link/businesswars.


Support us by supporting our sponsors!

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

2021-04-26 27 min
Listen elsewhere

Available Results

Generated results are saved to your library for reuse and search.

No generated results are available for this episode yet.

Transcript

No transcript is available for this episode yet.
Sign in to generate a transcript for review.
Sign in

Chapters

No chapters available.